"Mometasone Furoate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.
| Descriptor ID |
D000068656
|
| MeSH Number(s) |
D04.210.500.745.432.719.526
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mometasone Furoate".
Below are MeSH descriptors whose meaning is more specific than "Mometasone Furoate".
This graph shows the total number of publications written about "Mometasone Furoate" by people in this website by year, and whether "Mometasone Furoate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mometasone Furoate" by people in Profiles.
-
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021 07 22; 7:CD013877.
-
Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial. Int Immunopharmacol. 2021 Sep; 98:107871.
-
Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021 Mar-Apr; 42(2):102884.
-
Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted. J Med Virol. 2021 02; 93(2):637-638.
-
Management of chronic rhinosinusitis with steroid nasal irrigations: A viable nonsurgical alternative in the COVID-19 era. Int Forum Allergy Rhinol. 2020 09; 10(9):1108-1109.
-
Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report. Dermatol Ther. 2020 Jul; 33(4):e13616.
-
Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy. Acta Otorrinolaringol Esp (Engl Ed). 2020 May - Jun; 71(3):147-153.
-
How Should We Treat Patients with Mild Asthma? N Engl J Med. 2019 05 23; 380(21):2064-2066.
-
Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial. Ann Hematol. 2019 Apr; 98(4):841-849.
-
Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate. J Allergy Clin Immunol. 2019 04; 143(4):1395-1402.